Cuộc họp công bố kết quả kinh doanh Quý 3/2026 của Balchem (BCPC): Doanh thu và EBITDA điều chỉnh đạt mức kỷ lục
Cuộc họp báo công bố kết quả kinh doanh quý 3/2026 của Balchem: doanh thu tăng 8,6% lên mức kỷ lục 291 triệu USD, EBITDA điều chỉnh đạt 80 triệu USD và cả ba mảng kinh doanh đều tăng trưởng.
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.